Furthermore, overexpressed FBXO9 in multiple myeloma (MM) degraded TEL2 and TTI1, shifting signaling from mTORC1 to mTORC2, thus causing increased proliferation and survival [25]. This evidence concerns the gene TTI1 and Miyoshi myopathy.